PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
There is some evidence for the use of Drosera rotundifolia as a non-pharmacological remedy to relieve PAC [PMID:34461702]
Extracts of Drosera rotundifolia suppressed inflammatory gene and protein expression induced by activated T cell membrane [PMID:19540325]
European sundew species, including Drosera rotundifolia, demonstrate biofilm inhibitory activity against multidrug-resistant E. coli strains [PMID:36430196]
Evidence summary
PubMed sources
- 1.PMID: 36430196 (2022) — Antibiofilm Activity of Sundew Species against Multidrug-Resistant Escherichia coli Strains. · International journal of molecular sciences
- 2.PMID: 34208192 (2021) — Field-Grown and In Vitro Propagated Round-Leaved Sundew (Drosera rotundifolia L.) Show Differences in Metabolic Profiles and Biological Activities. · Molecules (Basel, Switzerland)
- 3.PMID: 37922526 (2024) — Quality parameters for the medicinal plant Drosera rotundifolia L.: A new approach with established techniques. · Archiv der Pharmazie
- 4.PMID: 24130022 (2013) — Phytochemistry of the carnivorous sundew genus Drosera (Droseraceae) - future perspectives and ethnopharmacological relevance. · Chemistry & biodiversity
- 5.PMID: 19540325